Pay in 4 interest-free payments of $6.71 Learn more
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21
the Danish cohort used other antidiabetic agents as the reference, while the Israeli study compared GLP-1RA users against non-users within the IBD-diabetes population, making cross-study comparison difficult
Contact your GP, diabetes specialist nurse, or NHS 111 if: Headaches are persistent, worsening, or significantly impacting daily activities despite simple management measures You experience frequent hypoglycaemic episodes (blood glucose below 4 mmol/L) [31] [32] You have signs of dehydration such as reduced urine output, excessive thirst, or dizziness when standing Side effects are affecting medication adherence or quality of life You develop new or unusual symptoms that concern you Headaches follow a different pattern from any pre-existing headache disorder Healthcare professionals can assess whether headaches are likely related to GLP-1 therapy or require investigation for alternative causes
Pace the Pounds: Avoid Rapid Weight Loss Rapid weight loss stresses the body and can trigger telogen effluvium
Telehealth is not a temporary trend
J Clin Endocrinol Metab (2001) 86:357994
The study researchers found the GLP-1 RA group had a two-fold higher risk of incident nAMD development than the non-GLP-1 RA group
